Nanotechnology and nanomedicine: A primer

Journal of the National Medical Association

Volumn 98, Issue 12, 2006, Pages 1985-1988

  Walker Jr , Bailus ^a,b,c   Mouton, Charles P ^a,b  

^a Howard University College of Medicine ^*

^b HOWARD UNIVERSITY HOSPITAL   (United States)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Nanomedicine; Nanotechnology

Indexed keywords

BIOMATERIAL; DNA; NANOFIBER; NANOMATERIAL;

BIOTECHNOLOGY; DIAGNOSTIC VALUE; ENVIRONMENTAL FACTOR; ETHICS; HEALTH CARE FACILITY; NANOMEDICINE; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SAFETY;

HUMANS; NANOMEDICINE; NANOTECHNOLOGY;

EID: 33845612301     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Thrall JM. Nanotechnology and medicine. Radiology. 2004;230:315-318.
2. Hassan MHA. Nanotechnology. Science. 2004;304:1732-1734.
3. European Industrial Research. Setting the nanotechnology research agenda. 2004 European Commission Directorate. Brussels, Belgium.
4. Feynman RP, Leighton RB, Sands M. The Feynman Lectures on Physics, vol. I. Reading MA: Addison Wesley Publishers; 1961.
5. Masciangioli T, Zhang W-X. Environmental technologies and the nanoscale. Environ Sci Technol. 2003:102A-108A.
6. Moghimi SM, Hunter AC, Murray, JC. Nanomedicine: current status and future prospects. FASEB J. 2005;19:311-330.
7. BECON Nanoscience and Nanotechnology Symposium Report, June 2000 National Institutes of Health Bioengineering Consortium, 2000. www.becon.nih.gov/becon symposium.htm. Accessed 06/05/06.
8. National Nanotechnology Initiative, www.nano.gov. Accessed 05/18/06.
9. Service RF. Nanotechnology: biology offers nanotechs a helping hand. Science. 2002;298:2322-2323.
10. Mazzola L. Commercializing nanotechnology. Nat Biotechnol. 2003;21: 1137-1143 [Medline].
11. Boeskey AL. Musculosketal disorders, an orthopedic condition. JAMA. 2001;285:619-623.
12. Service RF. Nanotechnology grows up. Science. 2004;304:1732-1734.
13. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate. N Eng J Med. 2003; 304:2491-2499.
14. NCI Alliance for Nanotechnology. Targeted nanoparticles enhance MRI detection, www.nano.gov. Accessed 06/17/06.
15. NCI Alliance for Nanotechnology. Planned clinical trials highlight first nanobiology. www.nano.gov. Accessed 06/14/06.
16. National nanotechnology initiative, www.nano.gov. Accessed 05/05/06.
17. U.S. Environmental Protection Agency. Nanotechnology and the Environment. Applications and Implications STAR Progress Review Workshop. EPA Document Number: EPA/000/R02/080 February 2003.
18. Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol. 2003;21:1166-1170.
19. Hunter AC, Moghimi SM. Therapeutic synthetic polymers, a game of Russian roulette? Drug Discov Today. 2002;7:98-100.
20. Shedova AA, Castranova V, Kisen ER, et al. Exposure to carbon nanomaterials: assessment of nanotube toxicity using human keratinocyte cells. J Toxicol Environ Health. 2003;66:1909-1926.
21. Dreher KL. Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles. Toxicol Sci. 2004;77: 3-5.